secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytoDyn Inc. (CYDY)
CIK:        0001175680
Form:       8-K
Filed at:   2024-06-03T23:59:59+00:00
Accession:  0001558370-24-008869
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

CytoDyn reports unregistered sale of 52.6M units at $0.13/unit, diluting equity by >5%
--------------------------------------------------------------------------------

- 52.6M units sold in private placement; 10.1M from note conversions, plus 1.5M follow-on units.
- Each unit: one common share and one warrant (exercise $0.21, 5-year term).
- Placement agent received 13% cash fee and warrants to purchase ~7.9M shares (10-year term).
- Follow-on offering netted ~$0.2M in proceeds.
- Aggregate unregistered sales exceeded 5% of shares outstanding as of March 28, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175680/000155837024008869/0001558370-24-008869-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175680/000155837024008869/cydy-20240528x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-008869

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer